Advertisement

IBC's 16th Annual Well Characterized Biologicals conference
30th October 2012 — 1st November 2012

00:35 EDT 23rd May 2013 | BioPortfolio

Perspectives on Protein Characterization, Product Comparability and Formulation Development for Biotechnology Products and Biosimilars

ACHIEVE SUCCESSFUL PRODUCT CHARACTERIZATION

No other conference provides more unpublished data, case studies and practical advice

FDA speakers will share their views on the agency's MOST RECENT priorities for product characterization through presentations, Q&A sessions and informal discussions. You'll benefit from direct interaction and advice from FDA scientists to help you meet regulatory expectations and quality standards for your products.

  • Complex Products
  • Function Assays/Bioassays
  • FDA's QbD Pilot Program
  • Biosimilars
  • Higher Order Structure
  • Particulates
  • Extractables & Leachables

New this year... covering a more diverse set of molecules through practical case studies and unpublished data that you can apply to your own projects:

  • ADC's
  • Biosimilars
  • Vaccines
  • Bispecifics
  • Immunoadhesin Proteins
  • Hemi-glycosylated IgGs
  • PEGylated Proteins

Avoid common pitfalls in your analytical characterization methods and regulatory interactions with the lessons learned from these top presenting companies: Pfizer, Sanofi-Pasteur, Genentech, GSK, Merck, Amgen, Abbott, MedImmune, Bristol-Myers Squibb, Boehringer-Ingelheim, Hoffmann-La Roche, Sandoz and more

Unpublished New Data
Hear case study presentations and unpublished results from 13 companies on a broad range of different molecules, that you can only hear by attending this conference.

Make New Contacts
Make new FDA and industry contacts by interacting with delegates, speakers and technology providers during networking breaks, luncheons and Q&A sessions.

Regulatory Advice You Can Apply
With 7 confirmed FDA speakers, and other regulatory expert speakers, you'll walk away from this conference with an update on changing regulatory guidelines and clearer regulatory expectations for your molecules. Many more FDA speaker invited to present...

You Ask, They Answer
Each conference session is followed by an interactive Q&A panel discussion which will allow you to get all your questions answered by conference speakers.

Scientific Poster Sessions
Learn about detailed projects and brainstorm ideas with poster presenters who are trying to find the right analytical approach for their biologicals. Take an active role in the conference and present a poster. Submit your poster abstract by Friday, September 28, 2012. Complete poster information

More Molecules, More Analytical Strategies
Covering a more diverse set of biologicals than ever before, you'll find strategies for characterizing ADC's, bispecifics, vaccines, biosimilars, PEGylated proteins, immunoadhesin proteins, hemi-glycosylated IgG's and others.

Expected Number of Attendees

NA

View Conference Website: IBC's 16th Annual Well Characterized Biologicals conference

Contact

Name: Howard Choi
Email: hchoi@ibcusa.com
Tel.: 508.614.1494
URL: Website

Price of Attendance

n/a

Brochure

View Event Brochure

Location

Omni Shoreham Hotel
Washington DC
United States
Washington D

Search BioPortfolio:
Advertisement
Advertisement